Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 48311701000001115 | Naprosyn (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 48311801000001112 | Naprosyn | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Naprosyn | Is a | Trade family | true | Inferred relationship | Existential restriction modifier | ||
| Naprosyn | Has trade family group | Naprosyn | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Naprosyn 125mg/5ml suspension (Roche Products Ltd) | Is a | True | Naprosyn | Inferred relationship | Existential restriction modifier | |
| Naprosyn 500mg tablets (PI) (Waymade Ltd) | Is a | True | Naprosyn | Inferred relationship | Existential restriction modifier | |
| Naprosyn 250mg tablets (Roche Products Ltd) | Is a | True | Naprosyn | Inferred relationship | Existential restriction modifier | |
| Naprosyn 500mg tablets (Roche Products Ltd) | Is a | True | Naprosyn | Inferred relationship | Existential restriction modifier | |
| Naprosyn 500mg suppositories (Roche Products Ltd) | Is a | True | Naprosyn | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR